Option Care Health (OPCH): CD&R and McKesson Agree to Buy Option Care for $5.8B at $32.05 a Share
CD&R and McKesson agreed to take Option Care Health private at $32.05 a share in cash, a ~$5.8B enterprise value and a 37% premium to Oct 5's close…
Home/Sector
Healthcare
3 takes
Bristol-Myers Squibb (BMY): Leerink cuts rating as pipeline doubts grow
Leerink Partners downgraded Bristol-Myers Squibb to Market Perform, cutting its price target to $59 from $73 — citing fading confidence in three…
Vaxcyte Shares Soar on Positive Phase 3 Vaccine Data ($PCVX)
Vaxcyte's pneumonia vaccine VAX-31 just hit all its goals in a major trial, matching or beating today's top shots from Pfizer and Merck. Shares…